text: Indiplon was discovered at Lederle Laboraties (subsequently acquired by American Cyanimid, which was acquired by Wyeth) in the 1980s and was called CL 285,489.:454 In 1998 Lederle licensed it, along with other early stage drug candidates, to Dov Pharmaceutical, a startup formed by former Lederle employees, and Dov exclusively sublicensed its rights in the drug to Neurocrine in that same year.